+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Tissue Banking Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Tissue Banking Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Tissue Banking Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6083315
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Tissue Banking Market grew from USD 37.13 billion in 2024 to USD 40.89 billion in 2025. It is expected to continue growing at a CAGR of 9.95%, reaching USD 65.61 billion by 2030.

Effective tissue banking underpins regenerative medicine and advanced therapeutics by preserving biological materials that drive breakthroughs in healthcare. As demand for personalized treatments and novel research applications continues to rise, the ability to reliably collect, process, and store tissues has become a cornerstone of clinical and laboratory practice. This study explores the multifaceted landscape of tissue banking, highlighting the critical role it plays in supporting reproductive health, drug discovery, stem cell research, and disease treatment.

Over the past decade, technological advancements in cryopreservation, automation, and cold chain logistics have enhanced the viability of stored tissues while reducing operational costs. Coupled with evolving regulatory requirements and shifting patient needs, these innovations are reshaping service delivery models and market dynamics. Industry participants are investing in sophisticated equipment, specialized media, and robust protocols to maintain sample integrity and traceability from initial collection through long-term storage.

By providing an integrated view of current capabilities, emerging trends, and competitive forces, this executive summary equips decision-makers, investors, and practitioners with actionable insights. It sets the stage for understanding transformative shifts, tariff impacts, segmentation nuances, regional strengths, and key players shaping the future of tissue banking.

Transformative Shifts Driving the Tissue Banking Market

The tissue banking landscape is undergoing transformative shifts fueled by technological breakthroughs, regulatory evolution, and strategic collaborations. Mastery of cryopreservation techniques has advanced from manual protocols to highly automated systems that ensure consistent temperature control and sample viability. Concurrently, digital platforms for inventory management and data analytics are enabling real-time monitoring, predictive maintenance, and streamlined workflows.

Regulatory bodies are increasingly harmonizing standards across regions, prompting operators to adopt best practices and validate processes against stringent quality benchmarks. Meanwhile, partnerships between academic institutions, biopharma companies, and specialized service providers are fostering integrated ecosystems that accelerate translational research and clinical application. Advances in cryoprotective agents and vitrification media are improving cell survival rates, while innovations in DNA/RNA extraction technologies are optimizing sample usability for genomics studies.

Looking ahead, artificial intelligence and machine learning are poised to revolutionize process optimization, risk assessment, and supply chain resilience. These transformative shifts are redefining competitive advantages, pushing market participants to invest in end-to-end solutions that combine equipment, consumables, and digital services.

Assessing the 2025 Impact of United States Tariffs on Tissue Banking

In 2025, the introduction of new tariff structures in the United States exerted significant pressure on import costs for critical tissue banking equipment and consumables. Increased duties on cryopreservation systems and specialized media compelled many operators to reassess supplier strategies and explore alternative sourcing channels. As a result, several service providers relocated production facilities, negotiated bulk purchase agreements, and consolidated their vendor portfolios to mitigate cost escalations.

These tariff adjustments also stimulated domestic manufacturing efforts, with established players ramping up local production capacities to capitalize on market opportunities. Nevertheless, certain advanced components remained subject to high duties, leading to selective stockpiling and the formation of strategic alliances with international manufacturers. Financial planning and procurement teams prioritized long-term contracts and hedging strategies to stabilize budgets and preserve service continuity.

Despite these challenges, the industry demonstrated resilience by leveraging economies of scale, optimizing logistics routes, and implementing lean inventory practices. Looking forward, ongoing dialogue with policymakers and active participation in trade associations will be crucial for shaping a more predictable regulatory framework and ensuring uninterrupted access to vital technologies.

Deep Dive into Key Segmentation Insights

Detailed segmentation analysis reveals how different facets of the tissue banking market interconnect to create value and define growth trajectories. By type, reproductive tissue banking encompasses embryo, oocyte, and semen preservation, each supported by tailored protocols and specialized media to maintain cellular integrity. In the application domain, research and development activities in drug discovery and stem cell research coexist with therapeutic services targeting autoimmune diseases and diabetes, underscoring the dual role of banking operations in innovation and patient care.

Service segmentation highlights the critical interplay between collection and processing workflows. Autologous and donor collection methodologies feed directly into cryopreservation and DNA/RNA extraction processes designed to uphold sample quality and traceability. End-user insights show that hospitals rely on rapid delivery and regulatory compliance, while research institutes prioritize high-throughput capabilities and flexible storage options.

Product categories bifurcate into equipment-constituting cryopreservation and storage systems-and media & consumables such as cryoprotective agents and vitrification solutions. Source segmentation differentiates between animal origins (bovine, porcine) and human tissues (adult, neonatal), each requiring distinct handling standards. Finally, therapeutic area segmentation spans cardiovascular disease interventions like heart failure treatment, neurological applications in Alzheimer’s, Parkinson’s, and stroke research, and oncology efforts against breast and lung cancers. Together, these segmentation layers provide a comprehensive map of market drivers and unmet needs.

Navigating Regional Dynamics and Growth Drivers

Regional dynamics underscore the global nature of tissue banking and the unique factors shaping each market. In the Americas, robust healthcare infrastructure and well-established reimbursement mechanisms accelerate adoption of advanced preservation technologies, while a strong emphasis on translational research fuels demand for high-quality samples. Europe, Middle East & Africa benefit from regulatory harmonization initiatives and public-private partnerships that enhance standardization and drive cross-border collaborations, even as cost containment pressures remain a consideration in certain jurisdictions.

In Asia-Pacific, rapid economic growth, expanding healthcare access, and government incentives have spurred investments in biobanking facilities and R&D centers. This region is witnessing a surge in domestic capabilities for cryopreservation equipment manufacturing and media development. Additionally, rising prevalence of chronic diseases and emphasis on personalized medicine are creating fertile ground for both service providers and technology innovators. Understanding these regional nuances enables stakeholders to tailor strategies that leverage local strengths and address market-specific challenges.

Profiling Leading Companies Shaping the Industry

The competitive landscape features a diverse array of global and specialized entities advancing tissue banking through product innovation, strategic alliances, and geographical expansion. Established equipment manufacturers deliver cutting-edge cryopreservation and storage systems, while media and consumables suppliers focus on enhancing cell viability and ease of use. Biotechnology firms are exploring novel preservation chemistries and automated workflows to differentiate their offerings.

Key participants span multiple tiers, from multinationals with broad portfolios to nimble startups targeting niche applications. Many companies are forging partnerships with academic centers and contract research organizations to co-develop next-generation solutions. Additionally, acquisitions and joint ventures are reshaping market contours, enabling participants to secure distribution networks and accelerate entry into emerging markets. Continuous investment in R&D, combined with an emphasis on service excellence and regulatory compliance, is critical for maintaining competitive advantage in this rapidly evolving sector.

Actionable Recommendations for Industry Leaders

To capitalize on evolving opportunities and navigate emerging challenges, industry leaders should adopt a multipronged approach. First, investing in research and development of advanced cryoprotective formulations and automated processing platforms will improve sample quality and operational efficiency. Second, diversifying sourcing strategies by cultivating regional manufacturing hubs and alternative supply chains will reduce vulnerability to trade disruptions.

Third, embracing digital transformation through integrated inventory management systems and predictive analytics will strengthen traceability, optimize storage utilization, and support data-driven decision-making. Fourth, proactive engagement with regulatory authorities and participation in standards bodies will help shape favorable policies and streamline product approvals. Fifth, forming strategic alliances with academic institutions, contract research organizations, and healthcare providers will foster collaborative innovation and accelerate time-to-market for new applications.

By aligning investments with clear market needs and maintaining agile operational models, leaders can drive sustainable growth, enhance resilience, and deliver superior value to customers and patients alike.

Conclusion: Charting the Future of Tissue Banking

The tissue banking sector stands at the intersection of technological innovation, clinical demand, and regulatory transformation. Through detailed analysis of market shifts, tariff impacts, segmentation nuances, regional trends, and competitive strategies, this executive summary has painted a comprehensive picture of current dynamics and future opportunities. Embracing automation, optimizing supply chains, and fostering strategic collaborations will be essential for sustainable success.

As stakeholders navigate an increasingly complex environment, the ability to anticipate regulatory changes, leverage emerging technologies, and align product portfolios with evolving applications will determine market leadership. Continuous investment in quality management systems, data analytics, and specialized personnel training will further strengthen operational excellence.

Ultimately, the organizations that combine deep domain expertise with agile innovation and robust stakeholder engagement will be best positioned to shape the future of tissue banking and unlock its full potential in improving patient outcomes and advancing scientific discovery.

Market Segmentation & Coverage

This research report categorizes the Tissue Banking Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Reproductive Tissue Bank
    • Embryo Banking
    • Oocyte Banking
    • Semen Banking
  • Research & Development
    • Drug Discovery
    • Stem Cell Research
  • Therapeutics
    • Autoimmune Disease Treatment
    • Diabetes Treatment
  • Collection
    • Autologous Collection
    • Donor Collection
  • Processing
    • Cryopreservation
    • DNA/RNA Extraction
  • Hospitals
  • Research Institutes
  • Equipment
    • Cryopreservation Systems
    • Storage Systems
  • Media & Consumables
    • Cryoprotective Agents
    • Vitrification Media
  • Animal Tissue Source
    • Bovine Tissue Source
    • Porcine Tissue Source
  • Human Tissue Source
    • Adult Tissue Source
    • Neonatal Tissue Source
  • Cardiovascular Diseases
    • Heart Failure
  • Neurology
    • Alzheimer's Disease
    • Parkinson's Disease
    • Stroke
  • Oncology
    • Breast Cancer
    • Lung Cancer

This research report categorizes the Tissue Banking Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Tissue Banking Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • BioKryo GmbH
  • Bluechiip Limited
  • Chernobyl Tissue Bank
  • Corning Incorporated
  • Eli Lilly & Company
  • Merck KGaA
  • Organ Recovery Systems, Inc.
  • Panasonic Corporation
  • PHC Holdings Corporation
  • QIAGEN N.V.
  • Sanofi SA
  • Taylor-Wharton International LLC
  • Thermo Fisher Scientific Inc.
  • VIVEX Biologics, Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Tissue Banking Market, by Type
8.1. Introduction
8.2. Reproductive Tissue Bank
8.2.1. Embryo Banking
8.2.2. Oocyte Banking
8.2.3. Semen Banking
9. Tissue Banking Market, by Application
9.1. Introduction
9.2. Research & Development
9.2.1. Drug Discovery
9.2.2. Stem Cell Research
9.3. Therapeutics
9.3.1. Autoimmune Disease Treatment
9.3.2. Diabetes Treatment
10. Tissue Banking Market, by Service
10.1. Introduction
10.2. Collection
10.2.1. Autologous Collection
10.2.2. Donor Collection
10.3. Processing
10.3.1. Cryopreservation
10.3.2. DNA/RNA Extraction
11. Tissue Banking Market, by End-User
11.1. Introduction
11.2. Hospitals
11.3. Research Institutes
12. Tissue Banking Market, by Product
12.1. Introduction
12.2. Equipment
12.2.1. Cryopreservation Systems
12.2.2. Storage Systems
12.3. Media & Consumables
12.3.1. Cryoprotective Agents
12.3.2. Vitrification Media
13. Tissue Banking Market, by Source
13.1. Introduction
13.2. Animal Tissue Source
13.2.1. Bovine Tissue Source
13.2.2. Porcine Tissue Source
13.3. Human Tissue Source
13.3.1. Adult Tissue Source
13.3.2. Neonatal Tissue Source
14. Tissue Banking Market, by Therapeutic Area
14.1. Introduction
14.2. Cardiovascular Diseases
14.2.1. Heart Failure
14.3. Neurology
14.3.1. Alzheimer's Disease
14.3.2. Parkinson's Disease
14.3.3. Stroke
14.4. Oncology
14.4.1. Breast Cancer
14.4.2. Lung Cancer
15. Americas Tissue Banking Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Tissue Banking Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Tissue Banking Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Beckman Coulter, Inc.
18.3.2. Bio-Rad Laboratories Inc.
18.3.3. BioKryo GmbH
18.3.4. Bluechiip Limited
18.3.5. Chernobyl Tissue Bank
18.3.6. Corning Incorporated
18.3.7. Eli Lilly & Company
18.3.8. Merck KGaA
18.3.9. Organ Recovery Systems, Inc.
18.3.10. Panasonic Corporation
18.3.11. PHC Holdings Corporation
18.3.12. QIAGEN N.V.
18.3.13. Sanofi SA
18.3.14. Taylor-Wharton International LLC
18.3.15. Thermo Fisher Scientific Inc.
18.3.16. VIVEX Biologics, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. TISSUE BANKING MARKET MULTI-CURRENCY
FIGURE 2. TISSUE BANKING MARKET MULTI-LANGUAGE
FIGURE 3. TISSUE BANKING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TISSUE BANKING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TISSUE BANKING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TISSUE BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TISSUE BANKING MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TISSUE BANKING MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TISSUE BANKING MARKET SIZE, BY SERVICE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TISSUE BANKING MARKET SIZE, BY SERVICE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TISSUE BANKING MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TISSUE BANKING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL TISSUE BANKING MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL TISSUE BANKING MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 20. GLOBAL TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS TISSUE BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS TISSUE BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES TISSUE BANKING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES TISSUE BANKING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. TISSUE BANKING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. TISSUE BANKING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TISSUE BANKING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TISSUE BANKING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TISSUE BANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TISSUE BANKING MARKET SIZE, BY EMBRYO BANKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TISSUE BANKING MARKET SIZE, BY OOCYTE BANKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TISSUE BANKING MARKET SIZE, BY SEMEN BANKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TISSUE BANKING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TISSUE BANKING MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TISSUE BANKING MARKET SIZE, BY AUTOIMMUNE DISEASE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TISSUE BANKING MARKET SIZE, BY DIABETES TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TISSUE BANKING MARKET SIZE, BY COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TISSUE BANKING MARKET SIZE, BY AUTOLOGOUS COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TISSUE BANKING MARKET SIZE, BY DONOR COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TISSUE BANKING MARKET SIZE, BY PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TISSUE BANKING MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TISSUE BANKING MARKET SIZE, BY DNA/RNA EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TISSUE BANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TISSUE BANKING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TISSUE BANKING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TISSUE BANKING MARKET SIZE, BY CRYOPRESERVATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TISSUE BANKING MARKET SIZE, BY STORAGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TISSUE BANKING MARKET SIZE, BY CRYOPROTECTIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TISSUE BANKING MARKET SIZE, BY VITRIFICATION MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TISSUE BANKING MARKET SIZE, BY BOVINE TISSUE SOURCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TISSUE BANKING MARKET SIZE, BY PORCINE TISSUE SOURCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TISSUE BANKING MARKET SIZE, BY ADULT TISSUE SOURCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TISSUE BANKING MARKET SIZE, BY NEONATAL TISSUE SOURCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TISSUE BANKING MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TISSUE BANKING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TISSUE BANKING MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TISSUE BANKING MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TISSUE BANKING MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TISSUE BANKING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TISSUE BANKING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TISSUE BANKING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 122. CANADA TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. CANADA TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 124. CANADA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. CANADA TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 126. CANADA TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 127. CANADA TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 128. CANADA TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 129. CANADA TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 130. CANADA TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. CANADA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. CANADA TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 133. CANADA TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 134. CANADA TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 135. CANADA TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 136. CANADA TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 137. CANADA TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 138. CANADA TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 139. CANADA TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 140. CANADA TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 141. MEXICO TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. MEXICO TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 143. MEXICO TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. MEXICO TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 145. MEXICO TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 146. MEXICO TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 147. MEXICO TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 148. MEXICO TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 149. MEXICO TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. MEXICO TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. MEXICO TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 152. MEXICO TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 153. MEXICO TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 154. MEXICO TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 155. MEXICO TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 156. MEXICO TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 157. MEXICO TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 158. MEXICO TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 159. MEXICO TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES TISSUE BANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. AUSTRALIA TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 202. AUSTRALIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 204. AUSTRALIA TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 205. AUSTRALIA TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 219. CHINA TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. CHINA TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 221. CHINA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. CHINA TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 223. CHINA TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 224. CHINA TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 225. CHINA TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 226. CHINA TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 227. CHINA TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. CHINA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. CHINA TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 230. CHINA TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 231. CHINA TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 232. CHINA TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 233. CHINA TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 234. CHINA TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 235. CHINA TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 236. CHINA TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 237. CHINA TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 238. INDIA TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. INDIA TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 240. INDIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. INDIA TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 242. INDIA TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 243. INDIA TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 244. INDIA TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 245. INDIA TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 246. INDIA TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. INDIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 248. INDIA TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 249. INDIA TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 250. INDIA TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 251. INDIA TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 252. INDIA TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 253. INDIA TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 254. INDIA TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 255. INDIA TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 256. INDIA TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 257. INDONESIA TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 258. INDONESIA TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 259. INDONESIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 268. INDONESIA TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 269. INDONESIA TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 270. INDONESIA TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 271. INDONESIA TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 276. JAPAN TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 277. JAPAN TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 278. JAPAN TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. JAPAN TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 280. JAPAN TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 281. JAPAN TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 282. JAPAN TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 283. JAPAN TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 284. JAPAN TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 285. JAPAN TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 286. JAPAN TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 287. JAPAN TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 288. JAPAN TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 289. JAPAN TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 290. JAPAN TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 291. JAPAN TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 292. JAPAN TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 293. JAPAN TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 294. JAPAN TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 308. MALAYSIA TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 309. MALAYSIA TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 310. MALAYSIA TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 311. MALAYSIA TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 312. MALAYSIA TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 313. MALAYSIA TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 314. PHILIPPINES TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 315. PHILIPPINES TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 316. PHILIPPINES TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. PHILIPPINES TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 318. PHILIPPINES TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 319. PHILIPPINES TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 320. PHILIPPINES TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 321. PHILIPPINES TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 322. PHILIPPINES TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 323. PHILIPPINES TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 324. PHILIPPINES TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 325. PHILIPPINES TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 333. SINGAPORE TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 334. SINGAPORE TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 335. SINGAPORE TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 336. SINGAPORE TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 337. SINGAPORE TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 338. SINGAPORE TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 339. SINGAPORE TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 340. SINGAPORE TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 341. SINGAPORE TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 342. SINGAPORE TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 343. SINGAPORE TISSUE BANKING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE TISSUE BANKING MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE TISSUE BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE TISSUE BANKING MARKET SIZE, BY ANIMAL TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE TISSUE BANKING MARKET SIZE, BY HUMAN TISSUE SOURCE, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE TISSUE BANKING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE TISSUE BANKING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 350. SINGAPORE TISSUE BANKING MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 351. SINGAPORE TISSUE BANKING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 352. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 353. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY REPRODUCTIVE TISSUE BANK, 2018-2030 (USD MILLION)
TABLE 354. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 355. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 356. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 357. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 358. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY COLLECTION, 2018-2030 (USD MILLION)
TABLE 359. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 360. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 361. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 362. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY EQUIPM

Companies Mentioned

  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • BioKryo GmbH
  • Bluechiip Limited
  • Chernobyl Tissue Bank
  • Corning Incorporated
  • Eli Lilly & Company
  • Merck KGaA
  • Organ Recovery Systems, Inc.
  • Panasonic Corporation
  • PHC Holdings Corporation
  • QIAGEN N.V.
  • Sanofi SA
  • Taylor-Wharton International LLC
  • Thermo Fisher Scientific Inc.
  • VIVEX Biologics, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Tissue Banking - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Tissue Banking - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Tissue Banking Market Report by Product, Application, Tissue Type, and Region 2024-2032 - Product Image

Tissue Banking Market Report by Product, Application, Tissue Type, and Region 2024-2032

  • Report
  • 144 Pages
  • Global
From
Tissue Banking Equipment and Consumables - Global Strategic Business Report - Product Image

Tissue Banking Equipment and Consumables - Global Strategic Business Report

  • Report
  • 189 Pages
  • Global
From
Global Cord Blood & Tissue Banking Industry Report - Market Size, Segmentation, & Forecasts, 2024 - Product Image

Global Cord Blood & Tissue Banking Industry Report - Market Size, Segmentation, & Forecasts, 2024

  • Report
  • 296 Pages
  • Global
From
Cord Blood Banking Services Market Size, Share & Trends Analysis Report By Service (Collection & Transportation, Processing), By Bank (Private, Public, Hybrid), By Component, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Cord Blood Banking Services Market Size, Share & Trends Analysis Report By Service (Collection & Transportation, Processing), By Bank (Private, Public, Hybrid), By Component, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From

About the Tissue Bank Market

The Tissue Bank market is a subset of the Blood Banking industry, which focuses on the collection, processing, and distribution of human tissue for transplantation. Tissue Banks are responsible for the procurement, processing, and distribution of human tissue, such as bone, skin, and heart valves, for transplantation. They are also responsible for the storage and distribution of tissue for research purposes. Tissue Banks must adhere to strict regulations and guidelines set by the Food and Drug Administration (FDA) and other regulatory bodies. Tissue Banks are typically operated by hospitals, universities, and other healthcare organizations. They are also operated by private companies, such as tissue banks that specialize in the collection and distribution of tissue for research purposes. Some companies in the Tissue Bank market include CryoLife, Inc., Musculoskeletal Transplant Foundation, LifeNet Health, and AlloSource. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.